R
Refeyn
Revolutionary new way to analyze molecules which enables the accurate mass measurement of single molecules in solution, in their native state and without the need for labels
About Refeyn
Refeyn, spun out of Oxford University in 2018, specializes in mass photometry, a groundbreaking technology that allows for the precise mass measurement of single molecules in their native state without the need for labels. This innovative approach opens new possibilities for bioanalytics and the study of biomolecular functions. Refeyn's compact, bench-top instruments require minimal installation and only a few microliters of sample, making them highly accessible to the scientific community. The software automates the acquisition process and performs mass analysis in minutes, enabling researchers to intuitively interpret mass distribution results without prior knowledge. Refeyn serves academic institutions, research laboratories, and pharmaceutical companies, operating in the bioanalytics market. The company's business model revolves around the sale of its mass photometry instruments and related software, generating revenue through direct sales and potentially through service contracts and maintenance agreements.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Oxford, United Kingdom
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Northpond Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Refeyn on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Refeyn on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.